SEC Form 4 research
| Issuer | Gossamer Bio, Inc. |
|---|---|
| Tickers | GOSS |
| Reporting owners | 32 |
| Officers and directors | 12 |
| Last public filing | 2026-09-25 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-25 | 2026-09-23 | Milligan Sandra | A | 10,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Daniel Thomas O | A | 10,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Ciongoli Gregory Austin | A | 30,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Drynan Skye | A | 10,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Quisel John D | A | 10,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Cox Russell J. | A | 10,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Nathan Steven D | A | 10,000 | $0 | Not reported |
| 2026-08-26 | 2026-08-24 | Smith Robert Paul JR | A | 5,800,051 | $0 | Not reported |
| 2026-08-26 | 2026-08-24 | Peterson Caryn | A | 5,800,051 | $0 | Not reported |
| 2026-08-26 | 2026-08-24 | Giraudo Bryan | A | 5,800,051 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.